Abstract:Background Lack of appropriate tools and techniques to study fate and functional integration of newly generated neurons has so far hindered understanding of neurogenesis' relevance under physiological and pathological conditions. Current analyses are either dependent on mitotic labeling, for example BrdU-incorporation or retroviral infection, or on the detection of transient immature neuronal markers. Here, we report a transgenic mouse model (DCX-CreERT2) for time-resolved fate analysis of newly generated neurons. This model is based on the expression of a tamoxifen-inducible Cre recombinase under the control of a doublecortin (DCX) promoter, which is specific for immature neuronal cells in the CNS. Results In the DCX-CreERT2 transgenic mice, expression of CreERT2 was restricted to DCX+ cells. In the CNS of transgenic embryos and adult DCX-CreERT2 mice, tamoxifen administration caused the transient translocation of CreERT2 to the nucleus, allowing for the recombination of loxP-flanked sequences. In our system, tamoxifen administration at E14.5 resulted in reporter gene activation throughout the developing CNS of transgenic embryos. In the adult CNS, neurogenic regions were the primary sites of tamoxifen-induced reporter gene activation. In addition, reporter expression could also be detected outside of neurogenic regions in cells physiologically expressing DCX (e.g. piriform cortex, corpus callosum, hypothalamus). Four weeks after recombination, the vast majority of reporter-expressing cells were found to co-express NeuN, revealing the neuronal fate of DCX+ cells upon maturation. Conclusions This first validation demonstrates that our new DCX-CreERT2 transgenic mouse model constitutes a powerful tool to investigate neurogenesis, migration and their long-term fate of neuronal precursors. Moreover, it allows for a targeted activation or deletion of specific genes in neuronal precursors and will thereby contribute to unravel the molecular mechanisms controlling neurogenesis.

Emx1-Specific Expression of Foreign Genes Using “Knock-In” Approach

Single cell derived murine embryonic stem cell clones stably express Rex1-specific green fluorescent protein and their differentiation study.

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

A Powerful Transgenic Tool for Fate Mapping and Functional Analysis of Newly Generated Neurons

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

A Transgenic Cre Mouse Line for the Study of Cortical and Hippocampal Development

Conditional gene targeting in mouse high endothelial venules

Cre Reconstitution Allows for Dna Recombination Selectively in Dual-Marker-Expressing Cells in Transgenic Mice

Hematopoietic Specific GATA-1-Improved Cre Mouse for Erythroid-Specific Gene Modification.

Construction and Tissue Specific Expression of Cre Transgenic Mice

Stable, neuron-specific gene expression in the mouse brain

Using reporter genes to label selected neuronal populations in transgenic mice for gene promoter, anatomical, and physiological studies

Establishing A Leukemia-inducible Model with ES Cells

Expression of corticotropin-releasing hormone transgenes in neurons of adult and developing mice

The Construction of a Cre Recombinase Expression Vector That Targets the Expression of Cre in Pancreas of Transgenic Mouse

Transgenic mouse model exhibiting weak red fluorescence before and strong green fluorescenceafter Cre/loxP-mediated recombination

Generation of Frizzled10-Cre transgenic mouse line: a useful tool for the study of dorsal telencephalic development.

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes

Efficient Generation of Mice with Consistent Transgene Expression by FEEST

Introduction of a Lacz Reporter Gene into the Mouse Int-2 Locus by Homologous Recombination.